<DOC>
	<DOCNO>NCT00538226</DOCNO>
	<brief_summary>This open label pilot study evaluate efficacy safety Flowaid device increase local circulation leg . 15 patient diagnosis Peripheral Vascular Disease enrol study . They recieve tratment Flowaid device monitor continuously mean Laser Doppler Flowmetry well tcPO2 Digital Thermography . Subjective data also collect .</brief_summary>
	<brief_title>Evaluation Effect Flowaid Device Increasing Local Circulation Leg</brief_title>
	<detailed_description>This 15 patient pilot study evaluate efficacy safety use Flowaid device increase local circulation leg patient Peripheral Vascular Disease . Patients evaluate scored prior treatment treat Flowaid device period two hour . During treatment period patient continuously monitor digital thermograph well tcPO2 Laser Doppler Flowmetry . Patients also monitor brief period immediately cessation treatment evaluate continue effect device local circulation leg . The study individually control patient treat leg evaluated contralateral non- treat leg . Subjective data include distance able walk , pain vibratory sensation threshold also collect evaluated appropriately .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Give appropriate write informed consent prior participation study Have current diagnosis Type I Type II Diabetes Mellitus Have AnkleArm Index 0.35 0.8 study limb Be reasonable metabolic control , exhibit HbA1C value less than12 % observed serum test result obtain within 3 month prior Screening Visit Subject caregiver must accessible , willing comply , safety procedure available 12 week FollowUp Period Clinical evidence gangrene part affect foot Active Charcot 's foot study limb Scheduled undergo vascular surgery , angioplasty , thrombolysis within 30 day end study Malnourished evidence prealbumin &lt; 11 mg/dL Pregnancy lactate History bleed disorder Participation another device study treatment Peripheral Vascular Disease 30 day prior Screening Visit Vascular procedure perform 30 day prior Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>